5,894
Views
54
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Adaptive radiotherapy strategies for pelvic tumors – a systematic review of clinical implementations

, , , , , & show all
Pages 943-958 | Received 23 Oct 2015, Accepted 14 Feb 2016, Published online: 08 Apr 2016

References

  • Meijer G, Rasch C, Remeijer P, Lebesque J. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2003;55:1277–87.
  • Van de Bunt L, Jürgenliemk-Schulz I, de Kort G, Roesink J, Tersteeg R, van der Heide UA. Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need? Radiother Oncol 2008;88:233–40.
  • Schmid MP, Mansmann B, Fredrico M, Dimopoulous JC, Georg P, Fidarova E, et al. Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study. Strahlenther Onkol 2013;189:238–44.
  • Lim K, Chan P, Dinniwell R, Fyles A, Haider M, Cho YB, et al. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modelling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 2008;70:126–33.
  • Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RAF. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 2009;74:766–73.
  • Thörnqvist S, Hysing LB, Zolnay AG, Söhn M, Hoogeman MS, Muren LP, et al. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer. Radiother Oncol 2013;109:344–9.
  • Bondar ML, Hoogeman MS, Mens JW, Quint S, Ahmad R, Dhawtal G, et al. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. Int J Radiat Oncol Biol Phys 2011;83:1617–23.
  • Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003;69:297–304.
  • Yan D, Vicini F, Wong J, Martinez A. Adaptive radiation therapy. Phys Med Biol 1997;42:123–32.
  • Yan D. Adaptive radiotherapy: merging principle into clinical practice. Semin Radiat Oncol 2010;20:79–83.
  • Martinez A, Yan D, Lockman D, Brabbins D, Kota K, Sharpe M, et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001;50:1226–34.
  • Brabbins D, Martinez A, Yan D, Lockman D, Wallace M, Gustafson G, et al. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Int J Radiat Oncol Biol Phys 2005;61:400–8.
  • Yan D, Ziaja E, Jaffray D, Wong J, Brabbins D, Vicini F, et al. The use of adaptive radiation therapy to reduce setup error: a prospective clinical study. Int J Radiat Oncol Biol Phys 1998;41:715–20.
  • Vargas C, Yan D, Kestin L, Krauss D, Lockman D, Brabbins D, et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys 2005;63:141–9.
  • Vargas C, Martinez A, Kestin L, Yan D, Grills I, Brabbins D, et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:1297–308.
  • Park S, Yan D, McGrath S, Dilworth J, Liang J, Ye H, et al. Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence. Int J Radiat Oncol Biol Phys 2012;83:947–52.
  • Nijkmap J, Pos F, Nuver T, de Jong R, Remeijer P, Sonke J-J, et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys 2008;70:75–82.
  • Vanasek J, Odrazka K, Dolezel M, Dusek L, Jarkovsky J, Hlavka A, et al. Searching for an appropriate image-guided radiotherapy method in prostate cancer-implications for safety margin. Tumori 2014;100:518–23.
  • Cheung P, Sixel K, Morton G, Loblaw A, Tirona R, Pang G, et al. Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int J Radiat Oncol Biol Phys 2005;62:418–25.
  • Deutschmann H, Kametriser G, Steininger P, Scherer P, Schöller H, Gaisberger C, et al. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate. Int J Radiat Oncol Biol Phys 2012;83:1624–32.
  • Xia P, Qi P, Hwang A, Kinsey E, Pouliot J, Roach M. Comparison of three strategies in management of independent movement of the prostate and pelvic lymph nodes. Med Phys 2010;37:5006–13.
  • Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:289–302.
  • Pötter R, Knocke RH, Fellner C, Baldass M, Reinthaller A, Kucera H. Definitive radiotherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1193-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 2000;4:159–72.
  • Weitman J, Pötter R, Waldhäusl C, Nechvile E, Kirisits C, Knocke T. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2005;62:468–78.
  • Dimopoulos J, Schmid M, Fidarova E, Berger D, Kirisits C, Pötter R. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Int J Radiat Oncol Biol Phys 2012;82:1180–8.
  • Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:14–155.
  • Pötter R, Georg P, Dimopoulos J, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100:116–23.
  • Tan L, Coles C, Hart C, Tait E. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. Clin Oncol (R Coll Radiol)2009;21:175–82.
  • Lindegaard J, Fokdal L, Kynde S, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013;53:1510–9.
  • Mazeron R, Glimore J, Dumas I, Champoudry J, Goulart J, Vanneste B, et al. Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer. Oncologist 2013;18:15–22.
  • Morgia M, Cuartero J, Walsh L, Lezioranski J, Keeler K, Xie J, et al. Tumor and normal tissue dosimetry changes during MR-guided pulsed-dose-rate (PDR) brachytherapy for cervical cancer. Radiother Oncol 2013;107:46–51.
  • Fokdal L, Tanderup K, Kynde Nielsen S, Kidmose Christensen H, Røhl L, Morre Pedersen E, et al. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC-ESTRO target concept. Radiother Oncol 2011;100:473–9.
  • Fokdal L, Ørtoft G, Hansen ES, Røhl L, Pedersen EM, Tanderup K, et al. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer. Brachytherapy 2014;13:554–61.
  • Nomden C, de Leeuw A, Roesink J, Tersteeg R, Moerland M, Witteveen P, et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience. Radiother Oncol 2013;107:69–74.
  • Mahantshetty U, Swamidas J, Khanna N, Engineer R, Merchant N, Deshpande D, et al. Reporting and validation of gynaecological groupe euopeen de curietherapie European society for therapeutic radiology and oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancer. Clin Oncol 2011;21:1110–6.
  • Chargari C, Magné N, Dumas I, Messai T, Vicenzi L, Gillion N, et al. Physics contribution and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2009;74:133–9.
  • Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 2012;103:305–13.
  • Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol 2014;135:231–8.
  • Beriwal S, Kannan N, Kim H, Houser C, Mogus R, Sukumvanich P, et al. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results. Clin Oncol 2011;23:685–90.
  • Assenholt MS, Vestergaard A, Kallehauge JF, Mohanmed S, Nielsen SK, Petersen JB, et al. Proof of principle: applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Brachytherapy 2014;13:361–8.
  • Heijkoop ST, Langerak TR, Quint S, Bondar L, Mens J, Heijmen BJ, et al. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMR. Int J Radiat Oncol Biol Phys 2014;90:673–9.
  • Haie-Meder C, Pötter R, van Limbergen E, Briot E, de Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (I): concepts and terms in 3D image-based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45.
  • Pötter R, Haie-Meder C, van Limbergen E, Barillot I, de Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.
  • International Commission on Radiation Units and Measurements (ICRU) Report 38. Dose and volume specification for reporting intracavitary brachytherapy in gynecology. 1985
  • Sur R, Clinkard J, Jones W, Taylor R, Close H, Chaturvedi A, et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin Oncol 1993;5:30–3.
  • Turner S, Swindell R, Bowl N, Marrs J, Brookes B, Read G, et al. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys 1997;39:355–60.
  • Foroudi F, Wong J, Kron T, Rolfo A, Haworth A, Roxby P, et al. Online adaptive radiotherapy for muscle-invasive bladder cancer: Results of a pilot study. Int J Radiat Oncol Biol Phys 2011;81:765–71.
  • Kron T, Wong J, Rolfo A, Pham D, Cramb J, Foroudi F. Adaptive radiotherapy for bladder cancer reduces integral dose despite daily volumetric imaging. Radiother Oncol 2010;97:485–7.
  • McDonald F, Lalondrelle S, Taylor H, Warren-Oseni K, Khoo V, McNair HA, et al. Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiation. Clin Oncol (R Coll Radiol) 2013;25:549–56.
  • Foroudi F, Pham D, Rolfo A, Bressel M, Tang CI, Tan A, et al. The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART. Radiother Oncol 2014;111:316–20.
  • Vestergaard A, Muren LP, Lindberg H, Jakobsen KL, Petersen JB, Elstrøm UV, et al. Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer. Acta Oncol 2014;53:997–1004.
  • Tuomikoski L, Korhonen J, Collan J, Keyriläinen J, Visapää H, Sairanen J, et al. Implementation of adaptive radiation therapy for urinary bladder carcinoma: imaging, planning and image guidance. Acta Oncol 2013;52:1451–7.
  • Murthy V, Master Z, Adurkar P, Mallick I, Mahantshetty U, Bakshi G, et al. 'Plan of the day' adaptive radiotherapy for bladder cancer using helical tomotherapy. Radiother Oncol 2011;99:55–60.
  • Meijer GJ, van der Toorn PP, Bal M, Schuring D, Weterings J, de Wildt M. High precision bladder cancer irradiation by integrating a library planning procedure of 6 prospectively generated SIB IMRT plans with image guidance using lipiodol markers. Radiother Oncol 2012;105:174–9.
  • Tuomikoski L, Collan J, Keyriläinen J, Visapää H, Saarilahti K, Tenhunen M. Adaptive radiotherapy in muscle invasive urinary bladder cancer–an effective method to reduce the irradiated bowel volume. Radiother Oncol 2011;99:61–6.
  • Pos FJ, Hulshof M, Lebesque J, Lotz H, van Tienhoven G, Moonen L, et al. Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int J Oncol Biol Phys 2006;64:862–8.
  • Passoni P, Fiorino C, Slim N, Ronzoni M, Ricci V, di Palo S, et al. Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. Int J Radiat Oncol Biol Phys 2013;87:67–72.
  • Lu W, Chen M, Ruchala KJ, Chen Q, Langen KM, Kupelian PA, et al. Real-time motion-adaptive-optimization (MAO) in TomoTherapy. Phys Med Biol 2009;54:4373–98.
  • Wu QJ, Thongphiew D, Wang Z, Mathayomchan B, Chankong V, Yoo S, et al. On-line re-optimization of prostate IMRT plans for adaptive radiation therapy. Phys Med Biol 2008;53:673–91.
  • Wu Q, Liang J, Yan D. Application of dose compensation in image-guided radiotherapy of prostate cancer. Phys Med Biol 2006;51:1405–19.
  • Li T, Zhu X, Thongphiew D, Lee WR, Vujaskovic Z, Wu Q, et al. On-line adaptive radiation therapy: feasibility and clinical study. J Oncol 2010;2010:407236.
  • Qi P, Pouliot J, Roach M 3rd, Xia P. Offline multiple adaptive planning strategy for concurrent irradiation of the prostate and pelvic lymph nodes. Med Phys 2014;41:021704–1-7.
  • Lim K, Stewart J, Kelly V, Xie J, Brock KK, Moseley J, et al. Dosimetrically triggered adaptive intensity modulated radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 2014;90:147–54.
  • Lalondrelle S, Huddart R, Warren-Oseni K, Nordmark Hansen V, McNair H, Thomas K, et al. Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer. Int J Oncol Biol Phys 2011;79:705–12.
  • Oh S, Stewart J, Moseley J, Kelly V, Lim K, Xie J, et al. Hybrid adaptive radiotherapy with on-line MRI in cervix cancer IMRT. Radiother Oncol 2014;110:323–8.
  • Stewart J, Lim K, Kelly V, Vie J, Brock K, Moseley J, et al. Automated weekly replanning for intensity-modulated radiotherapy of cervix cancer. Int J Radiat Oncol Biol Phys 2010;78:350–8.
  • Yang C, Liu F, Ahunbay E, Chang Y-E, Lawton C, Schultz C, et al. Combined online and offline adaptive radiation therapy: a dosimetric feasibility study. Pract Radiat Oncol 2014;4:e75–83.
  • Holubyev K, Bratengeier K, Gainey M, Polat B, Flentje M. Towards automated on-line adaptation of 2-step IMRT plans: QUASIMODO phantom and prostate cancer cases. Radiat Oncol 2013;8:263
  • Liu H, Wu Q. Evaluation of an adaptive planning technique incorporating dose feedback in image-guided radiotherapy of prostate cancer. Med Phys 2011;28:6362–70.
  • Battista JJ, Johnson C, Turnbull D, Kempe J, Bzdusek K, Van Dyk J, et al. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate. Int J Radiat Oncol Biol Phys 2013;87:874–80.
  • Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, et al. A fully automated method for CT-on-rails-guided online adaptive planning for prostate cancer intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 2013;86:835–41.
  • Li T, Thongphiew D, Zhu X, Lee WR, Vujaskovic Z, Yin FF, et al. Adaptive prostate IGRT combining online re-optimization and re-positioning: a feasibility study. Phys Med Biol 2011;56:1243–58.
  • Yan D, Wong J, Michalski J, Pan C, Frazier A, Horwitz E, et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment set-up errors. Int J Radiat Oncol Biol Phys 1997;38:197–206.
  • Boggula R, Lorenz F, Abo-Madyan Y, Lohr F, Wolff D, Boda-Heggemann J, et al. A new strategy for online adaptive prostate radiotherapy based on cone-beam CT. Z Med Phys 2009;19:264–76.
  • Birkner M, Yan D, Alber M, Liang J, Nüsslin F. Adapting inverse planning to patient and organ geometrical variation: algorithm and implementation. Med Phys 2003;30:2822–31.
  • Rehbinder H, Forsgren C, Löf J. Adaptive radiation therapy for compensation of errors in patient setup and treatment delivery. Med Phys 2004;31:22633371.
  • Court L, Dong L, Lee A, Cheung R, Bonnen M, O'Daniel J, et al. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys 2005;62:154–63.
  • Ahunbay EE, Peng C, Holmes S, Godley A, Lawton C, Li XA. Online adaptive replanning method for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2010;77:1561–72.
  • Liu H, Wu Q. Dosimetric and geometric evaluation of a hybrid strategy of offline adaptive planning and online image guidance for prostate cancer radiotherapy. Phys Med Biol 2011;56:5045–62.
  • Hwang AB, Chen J, Nguyen TB, Gottschalk AG, Roach MR, Pouliot J. Irradiation of the prostate and pelvic lymph nodes with an adaptive algorithm. Med Phys 2013;39:1119–24.
  • Haverkort MA, van de Kamer JB, Pieters BR, Koning CC, van Herk M, van Tienhoven G. Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?. Radiother Oncol 2012;105:203–6.
  • Li T, Wu Q, Zhang Y, Vergalasova I, Lee R, Fang-Fang L, et al. Strategies for automatic online treatment plan reoptimization using clinical treatment planning system: a planning parameters study. Med Phys 2013;40:1–14.
  • Liu F, Ahunbay E, Lawton C, Li A. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy. Med Phys 2014;41:031710–1-14.
  • Crijns W, Van Herck H, Defraence G, Van den Bergh L, Slagmolen P, Haustermans K, et al. Dosimetric adaptive IMRT driven by fiducial points. Med Phys 2014;41:061716–1-11.
  • Stanley K, Eade T, Kneebone A, Booth JT. Investigation of an adaptive treatment regime for prostate radiation therapy. Pract Radiat Oncol 2015;5:e23–9.
  • Song W, Wong E, Bauman S, Battisata J, van Dyk J. Dosimetric evaluation of daily rigid and nonrigid geometric correction strategies during on-line image-guided radiation therapy (IGRT) of prostate cancer. Med Phys 2007;34:352–65.
  • Feng Y, Castro-Pareja C, Shekhar R, Yu C. Direct aperture deformation: an interfraction image guidance strategy. Med Phys 2006;33:4490–8.
  • Ahnubay E, Peng C, Chen G-P, Yu C, Lawton C, Li A. An on-line replanning scheme for interfractional variations. Med Phys 2008;35:3607–15.
  • Mohan R, Zhang X, Wang H, Kang Y, Wang X, Liu H, et al. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys 2005;61:1258–66.
  • Beldjoudi G, Yartsev S, Bauman G, Battista J, van Dyk J. Schedule for CT image guidance in treating prostate cancer with helical tomotherapy. Br J Radiol 2010;83:241–51.
  • Schulze D, Liang J, Yan D, Zhang T. Comparison of various online IGRT strategies: The benefit of online treatment plan re-optimisation. Radiother Oncol 2009;90:367–76.
  • Bratengeier K, Polat B, Gainey M, Grewenig P, Meyer J, Flentje M. Is ad-hoc plan adaptation based on 2-step IMRT feasible? Radiother Oncol 2009;93:266–72.
  • Fu W, Yang Y, Yue NJ, Heron DE, Hug MS. A cone beam CT-guided online plan modification technique to correct interfractional anatomic changes for prostate cancer IMRT treatment. Phys Med Biol 2009;54:1691–703.
  • Thongphiew D, Wu J, Lee R, Chankong V, Yoo S, McMahon, et al. Comparison of online IGRT technique for prostate IMRT treatment: adaptive vs repositioning correction. Med Phys 2009;36:1651–62.
  • Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke T, Pötter R. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol 2003;68:51–9.
  • Ahmad R, Bondar L, Voet P, Mens J-W, Quint S, Dhawtal G, et al. A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins. a dosimetric evaluation. Acta Oncol 2013;52:1430–6.
  • Nagano A, Minohara S, Kato S, Kiyohara H, Ando K. Adaptive radiotherapy based on the daily regression of a tumor in carbon-ion irradiation. Phys Med Biol 2012;57:8343–56.
  • Ohkubo Y, Ohno T, Noda S, Kubo S, Nakagawa A, Kawahara M, et al. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer. J Radiat Res 2013;54:1138–45.
  • Wanderås A, Sundset M, Langdal I, Danielsen S, Frykholm G, Marthinsen A. Adaptive brachytherapy of cervical cancer, comparison of conventional point A and CT based individual treatment planning. Acta Oncol 2012;51:345–54.
  • Kerkhof E, Raaymakers B, van der Heide U, van de Blunt L, Jürgenliemk-Schultz I, Lagendijk J. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study. Radiother Oncol 2008;88:241–9.
  • Nielson CE, Yartsev S. A case study for online plan adaptation using helical tomotherapy. J Med Phys 2012;37:97–101.
  • Vestergaard A, Søndergaard J, Petersen JB, Høyer M, Muren LP. A comparison of three adaptive strategies in image-guided radiotherapy of bladder cancer. Acta Oncol 2010;49:1069–76.
  • Vestergaard A, Muren LP, Søndergaard J, Elstrøm UV, Høyer M, Petersen JB. Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: a dose accumulation comparison. Radiother Oncol 2013;109:457–62.
  • Wright P, Muren LP, Høyer M, Malinen E. Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling. Acta Oncol 2010;49:1045–51.
  • Webster GJ, Stratford J, Rodgers J, Livsey JE, Macintosh D, Choudhury A. Comparison of adaptive radiotherapy techniques for the treatment of bladder cancer. Br J Radiol 2013;86:20120433.
  • Foroudi F, Wong J, Haworth A, Baille A, McAlpine J, Rolfo A, et al. Offline adaptive radiotherapy for bladder cancer using cone beam computed tomography. J Med Imaging Radiat Oncol 2009;53:226–33.
  • Nijkmap J, Marijnen C, van Herk M, van Triest Sonke J-J. Adaptive radiotherapy for long course neo-adjuvant treatment of rectal cancer. Radiother Oncol 2012;103:353–9.
  • Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, et al. Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406. Int J Radiat Oncol Biol Phys 2012;83:e363–70.
  • Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006;24:1990–6.
  • Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al. High dose radiation delivery by intensity modulated conformal radiotherapy improves outcome of localized prostate cancer. J Urol 2001;166:876–81.
  • Beckendorf V, Guerif S, Le Prisé E, Cosset JM, Bougnoux A, Chauvet B, et al. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys 2011;80:1056–63.
  • Leborgne F, Fowler J. Late outcomes following hypofractionated conformal radiotherapy vs. Standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison. Int J Radiat Oncol Biol Phys 2009;74:1441–6.
  • Martin JM, Bayley A, Bristow R, Chung P, Gospodarowicz M, Menard C, et al. Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol 2009;4:50.
  • Burridge N, Amer A, Marchant T, Sykes J, Stratford J, Henry A, et al. Online adaptive radiotherapy of the bladder: small bowel irradiated-volume reduction. Int J Radiat Oncol Biol Phys 2006;66:892–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.